Specialization
Focus of research
Ethical aspects of personalized medicine for Alzheimer's Disease.
-
Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: a survey study
Waterink, L., Masselink, L. A., van der Lee, S. J., Visser, L. N. C., Cleutjens, S., van der Schaar, J., van Harten, A. C., Scheltens, P., Sikkes, S. A. M., van der Flier, W. M. & Zwan, M. D., 1 Dec 2024, In: Alzheimer's Research & Therapy. 16, 1, p. 1 1.Research output: Contribution to journal › Article › Academic › peer-review
-
Amyloid PET disclosure in subjective cognitive decline: Patient experiences over time
Hendriksen, H. M. A., de Rijke, T. J., Fruijtier, A., van de Giessen, E., van Harten, A. C., van Leeuwenstijn-Koopman, M. S. S. A., van der Schaar, J., Trieu, C., Visser, D., Smets, E. M. A., Visser, L. N. C. & van der Flier, W. M., 1 Aug 2024, (E-pub ahead of print) In: Alzheimer s & dementia.Research output: Contribution to journal › Article › Academic › peer-review
-
Impact of sharing Alzheimer's disease biomarkers with individuals without dementia: A systematic review and meta-analysis of empirical data
van der Schaar, J., Visser, L. N. C., Ket, J. C. F., Groot, C., Pijnenburg, Y. A. L., Scheltens, P., Bredenoord, A. L., van den Hoven, M. A. & van der Flier, W. M., 1 Dec 2023, In: Alzheimer's and Dementia. 19, 12, p. 5773-5794 22 p.Research output: Contribution to journal › Review article › Academic › peer-review
- All publications